As Plato said millennia ago, necessity is the mother of invention. We simply could not find an integrated, single source with the detailed coverage and access information and data we needed to rapidly respond to our partners‚ business challenges. So, we created one.

• We built an expanding library of source objects across all commercial and government health insurance products and offerings in all market segments and programs, from all payer types.
• We developed a cataloging system and methods tying them to the associated number of covered lives at the national and state level.
• We established an attribute creation and extraction engine necessary to develop the detailed coverage and access data points and insights our public and private partners required.
• We created a refined, centralized information repository with actionable insights and intel developed and ready to use
• We built a user-friendly platform to access the continually growing data sets and visualizations of key insights our partners need to inform critical strategic decisions.

Partially.
There is a wide array of public data sources and organizations from which some of the data in AXIACI is available. To date, we have not found a single, integrated resource ready to be leveraged for information and insights from either a top-down or bottom-up actual patient, provider, and other stakeholders‚ experience.
AXIACI was created because in our consulting work, we needed to look across commercial and government market segments and subsegments, find the answers to detailed coverage and access questions and tie together covered lives, states, carriers and employers to determine prevalence at the state and national level. We tried to find an existing source.
There are many data sets and information repositories, but they suffer in the same way our entire system suffers, as they are fragmented with multi-year lag times and the underlying sources they draw from are generally in response to a specific regulatory or transactional purpose for single/multiple stakeholders. The underlying data and information are gathered in a variety of ways -- self-reported, survey, operational transactions. There are limited ways to connect disparate data sets. Equally important, there is no integrated library of underlying source objects that can be easily accessed. Product developers, service providers, researchers, and policy makers have been working around these gaps to inform critical decisions for decades.
AXIACI is unique because it is a centralized and integrated resource through which public and private decision makers, analysts and researchers can access new, ready to use data, information, insights and intel on coverage and access to health care services prescription drugs beyond what is currently available from traditional and transactional data sources‚ and through which they can commission extractions for specific services and drugs.

No. There are many established sources that provide data and information on "what has happened."‚ through transactional and sales data. AXIACI focuses on access and coverage constructs and provides information, insights, and intel to establish possible market shifts, potential opportunities, or other "what can happen" scenarios and/or to help identify the factors that might explain "why and how" something happened.

No.
We do not rely on survey data.
We do not do surveys.

No. We source data and information that are in public domain and are both unstructured and structured.

Depends. Based on your purpose and needs, you can determine whether this new data is best used to augment or replace existing data. In many situations leveraging both existing transactional data and the new data in AXIACI can significantly enhance strategic decision making across multiple functions

Generally, yes, depending on the level of integration.
There are industry-specific identifiers that are normally used across solution modules of AXIACI that you can leverage.

The data is internally updated year round based on the cycle of each market segment. Release schedules call for updates on average of every 2-3 months.

LEVERAGE cross-sector experts with proven private and public experience across health care industries, regulatory agencies, and payor organizations developed the rules, methods, extraction and interactive engine.

No. It is available at both national and state level.

AXIACI market segments include:

• Commercial:
• Fully Insured - Health Insurer Carrier Individual and Small Group (On/Off Exchange), and Large Group
• Non-Federal Government Employer Sponsored Insurance (ESI) (State Government, Local/Municipal, School/District)
• Federal Government ESI
• Union/Taft-Hartley
• Non-Government ESI
• Government:
• Medicare and Medicare Advantage
• Medicaid and Medicaid Managed Care
• Tricare

Yes. By State/Geography and Market Sub-Segments. Leverage the Market Maven Solution in AXIACI Terminal.

Yes, you can. Leverage the iScope ECG Solution in AXIACI Terminal.

Yes. Leverage the nCASA I³ Solution in AXIACI Terminal.

Yes. Leverage the Market Maven, iScope ECG and nCASA I³ Solutions in AXIACI Terminal.

Yes. Leverage the Payer/PBM/Specialty module or Sourcing & Networks elements of the nCASA I³ Solution in AXIACI Terminal.

Yes. Leverage the Coverage elements of the nCASA I³ Solution in AXIACI Terminal.

Yes. Leverage the dHive Solution in AXIACI Terminal.

Yes. It provides deductible, maximum out-of-pocket (MOOP), co-pay and co-insurance rates. For employer-sponsored insurance (ESI), it also includes employee premium contribution where available.

Licensing the AXIACI Terminal Solutions or/and Specific Solution on a multi-year basis.

Yes. You can identify specific solution modules based on the established licensing model.

Yes. The platform can be customized with associated services cost to append to the licensed base

Cost is calculated based on the pricing model for the licensed solution modules of AXIACI Terminal (for example, the number of states, market segments, services, drugs or any other customization).

Yes. We provide training and technical support on the use of the platform. We also provide training on the use of the information and data and strategic consulting support

Yes. We have detailed operating and technical manuals for AXIACI and a sourcing guide.

Absolutely! The source objects in AXIACI have a massive amount of unstructured information to be mined. Our consulting services team at LEVERAGE will work with you to understand your needs, determine whether they can be met, and establish what additional information is needed along with the rules and logic necessary to extract the data. We have developed a process which includes a collaborative effort with you and your team during which the extraction approach will be defined, tested, and validated.

Yes. Our LEVERAGE team has extensive cross-sector expertise and has been providing strategic consulting services in the private and public sectors for over a decade.

Yes. Strategic decisions about Commercialization, Pricing of drug at launch, and R&D portfolio and pipeline investment can be enhanced with the data, information and intel in AXIACI

Many. Because this is the first time our client partners have had access to this type of intel, our initial engagements generally involve in-depth exploration of the business questions they face in different functional and strategic areas, as well as which areas of intel and information in AXIACI are best positioned to support them. Some examples of proven areas where we have seen it applied include:

• Strategy
• market access and coverage
• patient affordability
• opportunity and investments
• geo targeting
• marketing and sales
• pricing and forecasting
• patient payer health economics and outcomes research (P2HEOR)

Evaluate real-market opportunity based on area of investment; Validate and/or Enhance modeling and analysis to determine actual ROI; Identify areas for investments based on factual insights and intel driven by on-the-ground potential and use.

Yes. All the solutions of AXIACI are based on your specific purpose and need.

A Lot. The data information and intel can help you:

• Develop or enhance federal or state specific strategies for advocacy
• Evaluate the potential impact of legislative and regulatory proposals including how many people they would affect at a more granular level
• Determine their impact post-enactment and if they have not achieved results, evaluate why.
• Respond to changes in state, federal or payor policies.
• Analyze and identify specific barriers to patient access to services and drugs and coverage at state and payor levels

Yes. We have current partners directly accessing the sources in the AXIACI library and the platform extraction capabilities for federal grant funded research and others for whom we perform the initial extraction of data from AXIACI source objects and provide analysis tools and support.

Yes. The information and intelligence provides easy access to how covered lives are distributed in a state, how the state compares to others, differences coverage criteria for services and drugs by carrier/PBM, comparisons of coverage of government, non-government and small business insurance, prevalence of mental health, obesity and abortion coverage, and many other areas. We will respond to individual reporters where available.
Media outlets at the state or national level can license aspects of the platform on an annual basis and/or on an issue by issue time-limited basis to provide access to reporters and investigative reporters

It depends. One of the most helpful things it can provide is a rapid comparison of your state to others across multiple functional areas (an issue that often comes up with the governor and legislature!). You can either license access to the platform to do your own analysis or commission an analysis from our team. Depending on the issue, the turn-around time can be as little as two weeks. Examples include:

• aspects of state employee benefits such as:
• differences in pharmacy and specialty pharmacy benefit management
• range of plan choices
• employee cost sharing and premium contributions pooling of school districts and municipal employers
• coverage of specific services
• and more
• management of pharmacy benefits in states with Medicaid-managed care (MMC)
• cross section of ESI information on plan management and coverage of specific services and drugs (all exempt from state regulation)
• a full state landscape of behavioral health coverage across market segments (fully-insured, ESI, Medicare Advantage, or MMC)
• a landscape of the reach of carriers and PBMs across all market segments in the state
• many other areas

Yes.We have client partners for whom we provide strategic consulting and advisory services at a variety of levels and who use our data to refine their discovery and litigation strategies

Yes. We work in a variety of ways with policy partners interested in specific issues. Some use the platform to access the original source objects and use the extraction capabilities to do the research and extraction themselves; others use our consulting services to do the extraction and help with the analysis.

Yes. It provides carrier, employer, PBM, Spec PBM and other third-Party relationships such as BHOs; identifies when medical and pharmacy benefits are split in ESI and other key issues